Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Phase 2 Product Evaluation Single Sample Study - To Evaluate the Safety of the DiaSole Insole for Use on Patients With Diabetic Foot Ulcers

NCT05604352 is registered in ClinicalTrials.gov with Kaydiar Ltd as lead sponsor.

NCT NCT05604352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05604352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Phase 2 Product Evaluation Single Sample Study - To Evaluate the Safety of the DiaSole Insole for Use on Patients With Diabetic Foot Ulcers
Lead sponsor
Kaydiar Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2023
Completion date
May 15, 2023
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus foot ulcer